319 related articles for article (PubMed ID: 19596489)
1. Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients' home-nebulisers.
Reychler G; Leonard A; Van Ossel C; Godding V; Gigi J; Simon A; Lebecque P
J Hosp Infect; 2009 Aug; 72(4):351-7. PubMed ID: 19596489
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of efficacy of 5 methods of disinfection on mouthpieces and facemasks contaminated by strains of cystic fibrosis patients.
Reychler G; Aarab K; Van Ossel C; Gigi J; Simon A; Leal T; Lebecque P
J Cyst Fibros; 2005 Sep; 4(3):183-7. PubMed ID: 16046195
[TBL] [Abstract][Full Text] [Related]
3. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
Jakobsson B; Hjelte L; Nyström B
J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
[TBL] [Abstract][Full Text] [Related]
5. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
[TBL] [Abstract][Full Text] [Related]
6. Nebulizer use and maintenance by cystic fibrosis patients: a survey study.
Lester MK; Flume PA; Gray SL; Anderson D; Bowman CM
Respir Care; 2004 Dec; 49(12):1504-8. PubMed ID: 15571641
[TBL] [Abstract][Full Text] [Related]
7. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
[TBL] [Abstract][Full Text] [Related]
8. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
[TBL] [Abstract][Full Text] [Related]
9. Nebulizer cleaning and disinfection practices in families with cystic fibrosis: The relationship between attitudes, practice and microbe colonization.
Murray TS; O'Rourke TK; Feinn R; Drapeau G; Collins MS
J Cyst Fibros; 2019 Nov; 18(6):823-828. PubMed ID: 31126899
[TBL] [Abstract][Full Text] [Related]
10. Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.
Della Zuana A; Garcia Dde O; Juliani RC; Silva Filho LV
J Bras Pneumol; 2014; 40(2):119-27. PubMed ID: 24831395
[TBL] [Abstract][Full Text] [Related]
11. Bacterial contamination of cystic fibrosis clinics.
Zuckerman JB; Zuaro DE; Prato BS; Ruoff KL; Sawicki RW; Quinton HB; Saiman L;
J Cyst Fibros; 2009 May; 8(3):186-92. PubMed ID: 19250885
[TBL] [Abstract][Full Text] [Related]
12. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
[TBL] [Abstract][Full Text] [Related]
13. Inhalation equipment hygiene: a belgian national survey.
Reychler G; Bosschaerts M; Chevaillier J; Gaspar V; Lessire F; Opdekamp C; Van Ginderdeuren F; Vanlaethem S; Vreys M; Vrijsen B;
J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):239-43. PubMed ID: 19466909
[TBL] [Abstract][Full Text] [Related]
14. Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations.
Tabatabaii SA; Khanbabaee G; Sadr S; Farahbakhsh N; Aghdam MK; Lotfollahzadeh S; Hosseini A; Dara N; Nanbakhsh M; Gorji FA
BMC Pulm Med; 2020 Feb; 20(1):33. PubMed ID: 32028925
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
[TBL] [Abstract][Full Text] [Related]
16. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients.
Jakobsson BM; Onnered AB; Hjelte L; Nyström B
J Hosp Infect; 1997 Jul; 36(3):201-7. PubMed ID: 9253701
[TBL] [Abstract][Full Text] [Related]
17. Compliance in cystic fibrosis: an examination of infection control guidelines.
Masterson T; Wildman BG; Newberry B; Omlor G; Bryson E; Kukay A
Pediatr Pulmonol; 2008 May; 43(5):435-42. PubMed ID: 18361460
[TBL] [Abstract][Full Text] [Related]
18. Ozone disinfection of home nebulizers effectively kills common cystic fibrosis bacterial pathogens.
Towle D; Baker V; Schramm C; O'Brien M; Collins MS; Feinn R; Murray TS
Pediatr Pulmonol; 2018 May; 53(5):599-604. PubMed ID: 29542874
[TBL] [Abstract][Full Text] [Related]
19. Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation.
Monforte V; Román A; Gavaldà J; Bravo C; Rodriguez V; Ferrer A; Pahissa A; Morell F
Transplant Proc; 2005 Nov; 37(9):4056-8. PubMed ID: 16386625
[TBL] [Abstract][Full Text] [Related]
20. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.
Riquena B; Monte LFV; Lopes AJ; Silva-Filho LVRFD; Damaceno N; Aquino EDS; Marostica PJC; Ribeiro JD
J Bras Pneumol; 2019 May; 45(3):e20170351. PubMed ID: 31166553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]